Therapeutics News and Research

RSS

Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal dementia (FTD) in mice – and may even offer the potential to reverse some of the effects of the fatal diseases.

19 Feb 2024

Research demonstrates a bat species' resistance to cancer, pinpoints key genes

A study reveals Myotis pilosus bats exhibit exceptional cancer resistance through gene downregulation, offering insights into natural anticancer mechanisms.

18 Feb 2024

New study pinpoints key markers for Long COVID diagnosis

Study identifies elevated serologic responses and memory CD8+ T cell clonal expansion as key markers of Long COVID, offering insights into its pathology and potential diagnostic approaches.

18 Feb 2024

Researchers introduce a pioneering approach to combat neurodegenerative diseases

Researchers led by Northwestern University and the University of Wisconsin-Madison have introduced a pioneering approach aimed at combating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Amyotrophic lateral sclerosis (ALS).

16 Feb 2024

Optimizing chemotherapy for older adults with advanced cancer

Standard chemotherapy regimens, which are mostly based on testing in relatively young and healthy patients, may do more harm to older adults with cancer who often struggle with other health issues.

16 Feb 2024

New standards for evaluating aging biomarkers unveiled

A new paper led by Harvard researchers has zeroed in on biomarkers of aging using omic data from population-based studies.

16 Feb 2024

Study uncovers key genes and cell types that may affect pathogenesis of primary open-angle glaucoma

Although primary open-angle glaucoma (POAG) is the leading cause of blindness in people over the age of 55, there remains no cure for the disease and its biological mechanisms are not well understood.

16 Feb 2024

6th CKD Drug Development Summit: Countdown Begins

...

From 6th CKD Drug Development Summit 16 Feb 2024

Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing

In this interview, Chris Roberts of Aventa Genomics highlights the groundbreaking Aventa FusionPlus test, detailing its superior ability to detect gene fusions in cancer diagnostics and its pivotal role in advancing personalized oncology treatments.

From Aventa Genomics 16 Feb 2024

Antidepressant use during pregnancy linked to child brain development risks

A new study published in Nature Communications provides direct evidence that antidepressant use during pregnancy can impact a child's brain development and contribute to the risk of mental health disorders later in life.

16 Feb 2024

Columbia study reveals rare lipid's role in driving ferroptosis

Columbia researchers have found that a rare type of lipid is a key driver of ferroptosis, a form of cell death discovered by Columbia professor Brent Stockwell.

15 Feb 2024

Groundbreaking study sheds light on the potential of the heart to achieve self-repair and regeneration

A groundbreaking scientific study published in Nature Cardiovascular Research has unveiled a remarkable discovery that may have far-reaching implications for the treatment of heart disease.

14 Feb 2024

Researchers develop enhanced immunotherapy for multiple myeloma treatment

Immunotherapy is already improving treatment options for many cancer types, but research groups keep exploring ways to boost the body's immune response against the tumor.

14 Feb 2024

Phosphoproteomic profiling reveals the complex interplay of immune cells in tumors

Researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium of the National Institutes of Health, The University of Texas MD Anderson Cancer Center, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and others, have unveiled a detailed understanding of immune responses in cancer, marking a significant development in the field.

14 Feb 2024

Fluid-filled lung sac found to be the hub for virus-eating cells

Scientists have long thought of the fluid-filled sac around our lungs merely as a cushion from external damage. Turns out, it also houses potent virus-eating cells that rush into the lungs during flu infections.

14 Feb 2024

New breakthrough in pancreatic cancer research could help slow the disease's deadly spread

Scientists at Cold Spring Harbor Laboratory (CSHL) and the University of California, Davis have reached a new breakthrough in pancreatic cancer research-;eight years in the making. It could help slow the disease's deadly spread.

14 Feb 2024

Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions

Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals Clinical™ solution, a software-as-a-service (SaaS), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker clinical decisions and accelerated market delivery of therapeutics.

From Revvity 14 Feb 2024

Therapeutics News and Research

Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

Research demonstrates a bat species' resistance to cancer, pinpoints key genes

New study pinpoints key markers for Long COVID diagnosis

Researchers introduce a pioneering approach to combat neurodegenerative diseases

Optimizing chemotherapy for older adults with advanced cancer

New standards for evaluating aging biomarkers unveiled

Study uncovers key genes and cell types that may affect pathogenesis of primary open-angle glaucoma

6th CKD Drug Development Summit: Countdown Begins

Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing

Antidepressant use during pregnancy linked to child brain development risks

Columbia study reveals rare lipid's role in driving ferroptosis

Groundbreaking study sheds light on the potential of the heart to achieve self-repair and regeneration

Researchers develop enhanced immunotherapy for multiple myeloma treatment

Phosphoproteomic profiling reveals the complex interplay of immune cells in tumors

Fluid-filled lung sac found to be the hub for virus-eating cells

New breakthrough in pancreatic cancer research could help slow the disease's deadly spread

Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions

New AI-powered protein mapping tool optimizes cancer therapy

Cytokine interferon-gamma can be a disease-modifying therapeutic target in multiple system atrophy

Understanding how natural genetic variation contributes to adaptive responses to low oxygen

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News